Відео

Disease Focus: Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) and Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Speakers: Dr. Gabriel Brooks, Chief Medical Officer, Solid Biosciences Dr. Richie Khanna, VP of Non-Clinical and Bioanalytical Development, Lexeo Therapeutics Moderators: Dr. Chris Simpson, Executive VP and Chief Medical Executive, Ontario Health Dr. Shubhayan S...

Disease Focus: Long QT Syndrome (LQTS I, II, III), and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Speakers: Dr. Saumya Das, Chief Scientific Officer, Thryv Therepeutics Dr. Howard Surks, Chief Medical and Scientific Officer, Cardurion Pharmaceuticals Moderators: Dr. Ciorsti MacIntyre, Director, Inherited Heart Disease Program, QEII - Halifax Dr. Robert Hamilton, The Hospital f...

Disease Focus: Hypertrophic Cardiomyopathy (HCM), Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), and Dilated Cardiomyopathy (DCM) Speakers: Dr. Jonathan Schwartz, Chief Medical Officer, Rocket Pharmaceuticals Dr. Jeff Haroldson, Head of Medical Affairs, Tenaya Therapeutics Moderators: Dr. Thomas Roston, Cardiologist and Clinician-Scientist Ms. Paule Corneil, Patient Partner

Hear a brief overview of gene based therapeutics being developed for SADS conditions. Presented by: Dr. Jason Roberts, Cardiac Electrophysiologist, Hamilton Health Sciences

SADS Expert Insights - ICD Education: A Joint Clinician-Patient Approach

SADS Expert Insights: Brugada Syndrome - Investigating the Pediatric Aspects

SADS Expert Insights - Advancing Long QT Syndrome Understanding Through Stem Cells

Webinar 2 - Dr. Jason Roberts

Webinar 1 - Dr. Steven Brooks

Hearts Across Canada Official Auction Promotion

Hearts Across Canada Online Auction Official Launch Promo

Types of Genetic Variants - Made Easy!

The Warning Signs